THE use of cutting-edge Artificial Intelligence (AI) technology could lead to improved treatment for people living with multiple sclerosis (MS), according to new research funded by MS Australia.
A research team at the University of Sydney, led by Dr Heidi Beadnall, will explore how the latest advances in AI and imaging tech can improve diagnostic tools for MS.
According to MS Australia, "AI-driven analysis can eliminate the time-consuming manual process and enable the extraction of significantly more information from MRI scans", including brain lesion number, lesion volumes and brain volumes.
Improved diagnostic tools will assist neurologists in assessing the effectiveness of MS treatments and enable early intervention if necessary.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 23
